Bicycle Therapeutics Plc (BCYC)
3.36
-0.09
(-2.61%)
USD |
NASDAQ |
Nov 13, 16:00
3.36
0.00 (0.00%)
After-Hours: 19:59
Bicycle Therapeutics Price to Book Value : 0.4654 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 0.4779 |
| November 11, 2026 | 0.5112 |
| November 10, 2026 | 0.5112 |
| November 09, 2026 | 0.5222 |
| November 06, 2026 | 0.5001 |
| November 05, 2026 | 0.4821 |
| November 04, 2026 | 0.5153 |
| November 03, 2026 | 0.5084 |
| November 02, 2026 | 0.5015 |
| October 30, 2026 | 0.507 |
| October 29, 2026 | 0.5292 |
| October 28, 2026 | 0.5375 |
| October 27, 2026 | 0.5236 |
| October 26, 2026 | 0.5056 |
| October 23, 2026 | 0.4918 |
| October 22, 2026 | 0.5042 |
| October 21, 2026 | 0.4945 |
| October 20, 2026 | 0.4987 |
| October 19, 2026 | 0.4897 |
| October 16, 2026 | 0.4793 |
| October 15, 2026 | 0.4987 |
| October 14, 2026 | 0.4862 |
| October 13, 2026 | 0.5028 |
| October 12, 2026 | 0.5264 |
| October 09, 2026 | 0.5389 |
| Date | Value |
|---|---|
| October 08, 2026 | 0.5278 |
| October 07, 2026 | 0.5167 |
| October 06, 2026 | 0.525 |
| October 05, 2026 | 0.5555 |
| October 02, 2026 | 0.4682 |
| October 01, 2026 | 0.4931 |
| September 30, 2026 | 0.5098 |
| September 29, 2026 | 0.4994 |
| September 28, 2026 | 0.5076 |
| September 25, 2026 | 0.5042 |
| September 24, 2026 | 0.5103 |
| September 23, 2026 | 0.4926 |
| September 22, 2026 | 0.5103 |
| September 21, 2026 | 0.4967 |
| September 18, 2026 | 0.4994 |
| September 17, 2026 | 0.5035 |
| September 16, 2026 | 0.498 |
| September 15, 2026 | 0.5021 |
| September 14, 2026 | 0.5322 |
| September 11, 2026 | 0.5281 |
| September 10, 2026 | 0.524 |
| September 09, 2026 | 0.548 |
| September 08, 2026 | 0.5719 |
| September 04, 2026 | 0.5883 |
| September 03, 2026 | 0.5801 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Autolus Therapeutics Plc | 15.11 |
| DBV Technologies SA | 4.698 |
| Cellectis SA | 2.918 |
| Akari Therapeutics Plc | 0.6523 |
| Biodexa Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.807 |
| Price | 3.36 |
| Earnings Yield | -60.52% |
| Market Cap | 169.87M |